https://doi.org/10.4081/monaldi.2024.2907
Transplantation of heterozygous familial hypercholesterolemia living donor liver resulting in early myocardial infarction: a possible dangerous link
Submitted: January 9, 2024
Accepted: January 14, 2024
Published: January 16, 2024
Accepted: January 14, 2024
Abstract Views: 435
PDF_EARLY VIEW: 254
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Living donor liver transplantation (LDLT) is a lifesaving procedure that is often curative for several liver diseases. Familial hypercholesterolemia (FH) is a metabolic disease that results from an autosomal dominant mutation in the low-density lipoprotein receptor; yet, young patients with FH can live years without detection. Herein, we report a case of a patient who developed early myocardial infarction (MI) after having a transplant from a donor with undetected heterozygous FH. This was a 67-year-old female with non-alcoholic steatohepatitis-related liver cirrhosis, free from coronary artery disease, who underwent LDLT from her daughter, a 45-year-old female with no past medical history. One year post-transplant, she presented with an acute MI with a large atherosclerotic burden. Genetic analysis confirmed heterozygous FH in the donor but not in the recipient. This case emphasizes the importance of incorporating a thorough clinical history and lipid profile into pre-transplant testing for both the recipient and donor, as well as aggressive lipid-lowering therapy post-transplantation to avoid cardiovascular complications.
Goldaracena N, Barbas AS. Living donor liver transplantation. Curr Opin Organ Transplant 2019;24:131-7.
DOI: https://doi.org/10.1097/MOT.0000000000000610
Trotter JF. Selection of donors for living donor liver transplantation. Liver Transpl 2003;9:S2-7.
DOI: https://doi.org/10.1053/jlts.2003.50221
Neuberger J. An update on liver transplantation: a critical review. J Autoimmun 2016;66:51-9.
DOI: https://doi.org/10.1016/j.jaut.2015.08.021
Nikkilä K, Åberg F, Isoniemi H. Transmission of LDLR mutation from donor through liver transplantation resulting in hypercholesterolemia in the recipient. Am J Transplant 2014;14:2898-902.
DOI: https://doi.org/10.1111/ajt.12961
Kholaif N, Mohamed TI, Alharbi IS, et al. Management and clinical outcomes of patients with homozygous familial hypercholesteremia in Saudi Arabia. Monaldi Arch Chest Dis 2023;93. doi:10.4081/monaldi.2023.2503
DOI: https://doi.org/10.4081/monaldi.2023.2503
Al-Rasadi K, Al-Waili K, Al-Sabti HA, et al. Criteria for diagnosis of familial hypercholesterolemia: a comprehensive analysis of the different guidelines, appraising their suitability in the Omani Arab population. Oman Med J 2014;29:85-91.
DOI: https://doi.org/10.5001/omj.2014.22
Setia N, Saxena R, Arora A, Verma IC. Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations. Atherosclerosis 2016;255:31-6.
DOI: https://doi.org/10.1016/j.atherosclerosis.2016.10.028
Gilroy R, Heronemus M, Schmitt T, Moriarty P. Donors with familial hypercholesterolemia and clinical outcome in liver transplant recipients. Transplantation 2014;98:796.
DOI: https://doi.org/10.1097/00007890-201407151-02729
Popescu I, Habib N, Dima S, et al. Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: seven-yr follow-up. Clin Transplant 2009;23:565-70.
DOI: https://doi.org/10.1111/j.1399-0012.2008.00935.x
Liu C, Niu DM, Loong CC, et al. Domino liver graft from a patient with homozygous familial hypercholesterolemia. Pediatr Transplant 2010;14:E30-3.
DOI: https://doi.org/10.1111/j.1399-3046.2009.01133.x
Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
DOI: https://doi.org/10.1056/NEJMoa0807646
He K, Wang J, Shi H, et al. An interspecies study of lipid profiles and atherosclerosis in familial hypercholesterolemia animal models with low-density lipoprotein receptor deficiency. Am J Transl Res 2019;11:3116-27.
Ethics Approval
The study was approved by the office of research affairs and the Ethical Committee of our Institution (approval number: RAC 2191111).How to Cite
Kholaif, Naji, Lin Batha, Isra Elmahi, Sulaiman Alnaser, Sultan Alzaher, Norah Almallohi, Mosaad Alhussein, Dana Alhalees, and Ahmed Alshehri. 2024. “Transplantation of Heterozygous Familial Hypercholesterolemia Living Donor Liver Resulting in Early Myocardial Infarction: A Possible Dangerous Link”. Monaldi Archives for Chest Disease, January. https://doi.org/10.4081/monaldi.2024.2907.
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Vincenzo Capuano, Norman Lamaida, Rocco Capuano, Eduardo Capuano, Sergio Torre, Federica Marchese, Ernesto Capuano, Report on Non-fatal events cardio-cerebro-vascular to ten years in a Southern Italy cohort , Monaldi Archives for Chest Disease: Vol. 82 No. 4 (2014): Cardiac series
- Stefano Urbinati, Pompilio Faggiano, Furio Colivicchi, Carmine Riccio, Maurizio Giuseppe Abrignani, Alberto Genovesi-Ebert, Francesco Fattirolli, Stefania De Feo, Simona Gambetti, Massimo Uguccioni, After ACC/AHA and ESC Guidelines Pre-operative cardiological evaluation in non-cardiac surgery: certainties, controversial areas and opportunities for a team approach , Monaldi Archives for Chest Disease: Vol. 76 No. 3 (2011): Cardiac series
- F.J. de Serres, I. Blanco, E. Fernández-Bustillo, Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America , Monaldi Archives for Chest Disease: Vol. 71 No. 3 (2009): Pulmonary series
- Gennaro Ismeno, Antonio Falco, Francesco Paolo Tritto, Antonio d’Angelo, Francesco Longobardi, Girolamo Damiani, Joseph Marmo, Rosario Gregorio, Luigi Piazza, The use of “LAST†operation in high risk patient , Monaldi Archives for Chest Disease: Vol. 66 No. 1 (2006): Cardiac series
- Shekhar Kunal, Vijay Pathak, Keshav Pathak, Monika Mishra, Shashi Mohan Sharma, Sudhir Bhandari, Very late stent thrombosis associated with COVID-19 infection: a case report and review of the literature , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Abhay Joglekar, Subhasis Roy Choudhury, Chandra Vibhash, Manisha Kumar, Amit Gupta, Risk factors and outcome of antenatally diagnosed congenital diaphragmatic hernia following in-utero transfer in a busy public-sector tertiary care center in North India , Monaldi Archives for Chest Disease: Early Access
- Francesco Giallauria, Teresa Paragliola, Francesco Pilerci, Domenico Del Forno, Anna De Lorenzo, Athanasio Manakos, Rosa Lucci, Marianna Psaroudaki, Mariantonietta D’Agostino, Carlo Vigorito, Role of smokers in the household and of cardiac rehabilitation in smoking behaviour after acute myocardial infarction , Monaldi Archives for Chest Disease: Vol. 64 No. 2 (2005): Cardiac series
- Annamaria Municinó, Annamaria Nicolino, Manlio Milanese, Edoardo Gronda, Bruno Andreuzzi, Fabrizio Oliva, Francesco Chiarella, Hydrotherapy in Advanced Heart Failure: the Cardio-HKT Pilot Study , Monaldi Archives for Chest Disease: Vol. 66 No. 4 (2006): Cardiac series
- G.C. Maglaras, S. Katsenos, J. Kakadelis, C. Katsanos, Z. Metafratzi, D.G. Stefanou, M.P. Vassiliou, S.H. Constantopoulos, Primary angiosarcoma of the lung and pleura , Monaldi Archives for Chest Disease: Vol. 61 No. 4 (2004): Pulmonary series
- Angelica Cersosimo, Giuliana Cimino, Ludovica Amore, Emiliano Calvi, Greta Pascariello, Riccardo Maria Inciardi, Carlo Mario Lombardi, Enrico Vizzardi, Marco Metra, Cardiac biomarkers and mortality in COVID-19 infection: A review , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
You may also start an advanced similarity search for this article.
